Characteristics | NLR | P | |
---|---|---|---|
≤2.1 (n = 130) >2.1 (n = 92) | |||
Gender (male vs female) | 111 vs 19 | 78 vs 14 | NS |
Age | 52.0 ± 11.3 | 55.1 ± 10.0 | 0.049 |
Albumin (g/L) | 41.81 ± 5.13 | 42.13 ± 4.77 | NS |
ALT (U/L) | 59.88 ± 82.22 | 64.65 ± 110.44 | NS |
AST (U/L) | 39.25 ± 20.63 | 54.99 ± 83.46 | NS |
TB (mg/dL) | 0.84 ± 0.34 | 1.16 ± 1.08 | 0.012 |
Cr (mg/dL) | 0.87 ± 0.17 | 0.98 ± 0.78 | NS |
Lymphocyte counts (109/L) | 1.80 ± 0.66 | 1.20 ± 0.50 | <0.001 |
Neutrophil counts (109/L) | 2.59 ± 0.83 | 4.70 ± 2.61 | <0.001 |
WBC counts (109/L) | 4.90 ± 1.45 | 6.49 ± 2.79 | <0.001 |
HBsAg (positive vs negative) | 118 vs 12 | 72 vs 20 | 0.011 |
Anti-HCV (positive vs negative) | 1 vs 129 | 0 vs 92 | NS |
AFP (ng/mL) (≤20 vs >20) | 51 vs 79 | 40 vs 52 | NS |
INR | 1.02 ± 0.077 | 1.03 ± 0.09 | NS |
Platelet counts (109/L) | 137.36 ± 57.08 | 134.16 ± 62.42 | NS |
Vascular invasion (yes vs no) | 25 vs 105 | 24 vs 68 | NS |
Tumor differentiation (I–II vs III–IV) | 94 vs 36 | 73 vs 19 | NS |
Tumor encapsulation (yes vs no) | 50 vs 80 | 45 vs 47 | NS |
Tumor size (≤3.0 vs >3.0) | 74 vs 56 | 40 vs 52 | NS |
TNM stage (I–II vs IIIA) | 108 vs 22 | 70 vs 22 | NS |
Postoperative TACE (yes vs no) | 37 vs 93 | 32 vs 60 | NS |
Re-operation (yes vs no) | 10 vs 120 | 6 vs 86 | NS |